Regeneron’s trial therapy improves hearing in children with gene mutations
Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.
Drugs
Health
Medical
Drugs
Health
Pharma
USFDA gives nod to Janssen Research’s blood cancer therapy
The US Food and Drug Administration has approved the Darzalex Faspro combination drug therapy of Janssen Research and Development for treating blood cancer.